BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28592101)

  • 1. [Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C].
    Nie L; Wang XC; Niu JQ; Shang J; Han Y; Xin GJ; Jia G; Li JL; Ding GW; Liu ZF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):546-550. PubMed ID: 28592101
    [No Abstract]   [Full Text] [Related]  

  • 2. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
    Montella M; Polesel J; La Vecchia C; Dal Maso L; Crispo A; Crovatto M; Casarin P; Izzo F; Tommasi LG; Talamini R; Franceschi S
    Int J Cancer; 2007 Apr; 120(7):1555-9. PubMed ID: 17205531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergistic effect of HBV infection, alcohol and raw fish consumption on oncogenisis of primary hepatic carcinoma].
    Qiu XQ; Tan SK; Yu HP; Zeng XY; Li LQ; Hu L
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):113-5. PubMed ID: 18646693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area.
    Jang ES; Jeong SH; Lee SH; Hwang SH; Ahn SY; Lee J; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kim HY
    Liver Int; 2013 Aug; 33(7):1092-9. PubMed ID: 23651110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
    Kim GA; Han S; Kim HD; An J; Lim YS
    J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
    Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
    Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
    Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.
    Shim JJ; Oh CH; Kim JW; Lee CK; Kim BH
    Scand J Gastroenterol; 2017 Sep; 52(9):1029-1036. PubMed ID: 28562104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.
    Shen YC; Hsu C; Cheng CC; Hu FC; Cheng AL
    Oncology; 2012; 82(5):275-89. PubMed ID: 22555181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
    Trichopoulos D; Bamia C; Lagiou P; Fedirko V; Trepo E; Jenab M; Pischon T; Nöthlings U; Overved K; Tjønneland A; Outzen M; Clavel-Chapelon F; Kaaks R; Lukanova A; Boeing H; Aleksandrova K; Benetou V; Zylis D; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-De-Mesquita HB; Van Kranen HJ; Peeters PH; Lund E; Quirós JR; González CA; Sanchez Perez MJ; Navarro C; Dorronsoro M; Barricarte A; Lindkvist B; Regnér S; Werner M; Hallmans G; Khaw KT; Wareham N; Key T; Romieu I; Chuang SC; Murphy N; Boffetta P; Trichopoulou A; Riboli E
    J Natl Cancer Inst; 2011 Nov; 103(22):1686-95. PubMed ID: 22021666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiologic fraction and interaction of risk factors for primary hepatic carcinoma in Guangxi, China].
    Tan SK; Qiu XQ; Yu HP; Zeng XY; Xiao ZM; Hu L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Mar; 42(3):169-72. PubMed ID: 18788580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
    Park YH; Kim BK; Kim JK; Kim HC; Kim DY; Park JY; Han KH; Kim SU; Shin SH; Hahn KY; Ahn SH
    J Gastroenterol Hepatol; 2014 May; 29(5):1005-11. PubMed ID: 24325579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan.
    Mori M; Hara M; Wada I; Hara T; Yamamoto K; Honda M; Naramoto J
    Am J Epidemiol; 2000 Jan; 151(2):131-9. PubMed ID: 10645815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients.
    Chen TM; Chang CC; Huang PT; Wen CF; Lin CC
    Aliment Pharmacol Ther; 2013 Jan; 37(2):243-51. PubMed ID: 23171385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
    Hassan MM; Hwang LY; Hatten CJ; Swaim M; Li D; Abbruzzese JL; Beasley P; Patt YZ
    Hepatology; 2002 Nov; 36(5):1206-13. PubMed ID: 12395331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.
    Kuper H; Tzonou A; Kaklamani E; Hsieh CC; Lagiou P; Adami HO; Trichopoulos D; Stuver SO
    Int J Cancer; 2000 Feb; 85(4):498-502. PubMed ID: 10699921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.